For the quarter ending 2025-06-30.
| Income Statement | 2025-06-30 | |||
|---|---|---|---|---|
| Interest income and other, net | 6,210 | |||
| Loss from operations | -115,824 | |||
| Interest expense | 1,137 | |||
| Net loss before income tax | -110,751 | |||
| Income tax expense | 753 | |||
| Net loss | -111,504 | |||
| Foreign currency translation adjustments | -19 | |||
| Unrealized loss on marketable securities | -244 | |||
| Total other comprehensive loss | -263 | |||
| Comprehensive loss | -111,767 | |||
| Basic EPS | -0.71 | |||
| Diluted EPS | -0.71 | |||
| Basic Average Shares | 157,880,203 | |||
| Diluted Average Shares | 157,880,203 | |||
89bio, Inc. (ETNB)
89bio, Inc. (ETNB)